New drug improves prognosis in advanced breast cancer cases Los Angeles Daily News The drug everolimus (brand name Afinitor, from drug manufacturer Novartis) has been approved as a treatment for postmenopausal women with advanced hormone receptor-positive, or HR+, breast cancer. Everolimus is used in combination with the drug ... |
